64 related articles for article (PubMed ID: 3480074)
1. Escape of hybridomas from cellular defense mechanisms: an in vitro study using autologous and allogeneic lymphocytes.
Zänker KS; Blümel G; Lange J; Siewert JR
Cancer Detect Prev Suppl; 1987; 1():91-6. PubMed ID: 3480074
[TBL] [Abstract][Full Text] [Related]
2. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
Giovarelli M; Musiani P; Garotta G; Ebner R; Di Carlo E; Kim Y; Cappello P; Rigamonti L; Bernabei P; Novelli F; Modesti A; Coletti A; Ferrie AK; Lollini PL; Ruben S; Salcedo T; Forni G
J Immunol; 1999 Nov; 163(9):4886-93. PubMed ID: 10528190
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
[TBL] [Abstract][Full Text] [Related]
4. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
5. [Hybridomas synthesizing monoclonal antibodies to surface antigens of human lymphocytes].
Seregina TM; Mekshenkov MI
Tsitologiia; 1986 Sep; 28(9):976-80. PubMed ID: 3798564
[TBL] [Abstract][Full Text] [Related]
6. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
7. Specific cytotoxicity of a long-term cultured T-cell clone on human autologous mammary cancer cells.
Sato T; Sato N; Takahashi S; Koshiba H; Kikuchi K
Cancer Res; 1986 Sep; 46(9):4384-9. PubMed ID: 3488124
[TBL] [Abstract][Full Text] [Related]
8. Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic mice.
Schmitz J; Reali E; Hodge JW; Patel A; Davis G; Schlom J; Greiner JW
Cancer Res; 2002 Sep; 62(17):5058-64. PubMed ID: 12208761
[TBL] [Abstract][Full Text] [Related]
9. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
Bonavida B; Katz J
J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
[TBL] [Abstract][Full Text] [Related]
10. Lack of expression of a 31/33kD surface protein on human colon carcinoma cells is a marker for metastasizing potential.
Puhlmann CM; Freiberg B; Anderer FA
Anticancer Res; 1994; 14(6B):2701-7. PubMed ID: 7872705
[TBL] [Abstract][Full Text] [Related]
11. Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM.
Astaldi GC; Wright EP; Willems C; Zeijlemaker WP; Janssen MC
J Immunol; 1982 Jun; 128(6):2539-42. PubMed ID: 6804563
[TBL] [Abstract][Full Text] [Related]
12. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
Giovarelli M; Santoni A; Forni G
J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
[TBL] [Abstract][Full Text] [Related]
13. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
Strike LE; Devens BH; Lundak RL
J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
[TBL] [Abstract][Full Text] [Related]
14. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
15. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
Fan J; Bonavida B
J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
[TBL] [Abstract][Full Text] [Related]
16. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
17. Biological properties of the human colonic adenocarcinoma cell line SW 620 grown as a xenograft in the athymic mouse.
Stragand JJ; Barlogie B; White RA; Drewinko B
Cancer Res; 1981 Sep; 41(9 Pt 1):3364-9. PubMed ID: 7260902
[TBL] [Abstract][Full Text] [Related]
18. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
20. Anti-T3 antibody both activates and inhibits the cytotoxic activity of human T cell clones.
Hoffman RW; Quinones RR; Shaw S
Behring Inst Mitt; 1985 Aug; (77):30-8. PubMed ID: 3936472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]